First read for a new ticker takes about 20–30 seconds while we build the analysis from the latest fundamentals, estimates, and intelligence. It's saved after this, so future visits are instant.
Thesis: Pediatrix Medical: the story is balanced — Medicaid reimbursement rate changes at state level - affects 50% of patient mix and directly impacts margins
value - Trading at 1.0x sales and 8.4x EV/EBITDA with 9.9% FCF yield despite negative operating margins suggests deep value investors…
Rising interest rates increase borrowing costs on the company's debt (0.72 debt/equity ratio)…
Watch on earnings: US birth rate trends (CDC monthly data) - leading indicator of addressable market size, State Medicaid reimbursement rate changes - particularly in high-exposure states like Florida, Texas, California, Neonatologist supply and compensation trends (AAP workforce data) - affects physician recruitment costs.
One Sentence Summary:
Pediatrix Medical: the story is balanced — medicaid reimbursement rate changes at state level - affects 50% of patient mix and directly impacts margins.
Auto-composed from Stock Alarm intelligence, financial statements, and analyst estimates. Not investment advice.